Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 6642

Sort by

Sort Order Select

Journal Articles

Measurable residual disease and posttransplantation gilteritinib maintenance for patients with FLT3-ITD –mutated AML

Blood (2025) 145 (19): 2138–2148.

https://doi.org/10.1182/blood.2024025154

Published: 2025

Includes: Supplemental data

Journal Articles

CpG island methylator phenotype classification improves risk assessment in pediatric T-cell acute lymphoblastic leukemia

Fernanda Schäfer Hackenhaar, Nina Refhagen, Melanie Hagleitner, Frank van Leeuwen, Hanne Vibeke Marquart, Hans Ole Madsen, Mattias Landfors, Pia Osterman, Kjeld Schmiegelow, Trond Flaegstad, Ólafur Jónsson, Jukka Kanerva, Jonas Abrahamsson, Mats Heyman, Ulrika Norén Nyström, Magnus Hultdin, Sofie Degerman

Blood (2025) 145 (19): 2161–2178.

https://doi.org/10.1182/blood.2024026027

Published: 2025

Includes: Supplemental data

Journal Articles

The JAK2 46/1 haplotype influences PD-L1 expression

Gonzalo Carreño-Tarragona, María Tiana, Raquel Rouco, Alejandra Leivas, Jesús Victorino, Roberto García-Vicente, Andrew J. Chase, Andrea Maidana, William J. Tapper, Rosa Ayala, Nicholas C. P. Cross, Joaquín Martínez-López, Miguel Manzanares

Blood (2025) 145 (19): 2196–2201.

https://doi.org/10.1182/blood.2023023787

Published: 2025

Includes: Supplemental data

Journal Articles

STING activation improves T-cell-engaging immunotherapy for acute myeloid leukemia

Andreas Linder, Daniel Nixdorf, Niklas Kuhl, Ignazio Piseddu, TengTeng Xu, Anne V. Holtermann, Gunnar Kuut, Rebekka Endres, Nora Philipp, Veit Bücklein, Johann de Graaff, Thomas Carell, Sebastian Kobold, Roman Kischel, Veit Hornung, Marion Subklewe

Blood (2025) 145 (19): 2149–2160.

https://doi.org/10.1182/blood.2024026934

Published: 2025

Includes: Supplemental data

Journal Articles

Hu L, Shi Y, Hsu J, Gera J, Van Ness B, Lichtenstein A. Downstream effectors of oncogenic ras in multiple myeloma cells. Blood . 2003;101(8):3126-3135.

Blood (2025) 145 (19): 2232.

https://doi.org/10.1182/blood.2025029190

Published: 2025

Journal Articles

Lee HJ, Ramchandren R, Friedman J, et al. Brentuximab vedotin, nivolumab, doxorubicin, and dacarbazine for advanced-stage classical Hodgkin lymphoma. Blood. 2025;145(3):290-299.

Blood (2025) 145 (19): 2231.

https://doi.org/10.1182/blood.2025029278

Published: 2025

Journal Articles

3D insights: JAK2 46/1 haplotype shapes MPN development

Inge van der Werf, Catriona H. M. Jamieson

Blood (2025) 145 (19): 2112–2114.

https://doi.org/10.1182/blood.2025028547

Published: 2025

Journal Articles

From prognostication to precision in acute myeloid leukemia

Christopher S. Hourigan

Blood (2025) 145 (19): 2105–2106.

https://doi.org/10.1182/blood.2024028105

Published: 2025

Journal Articles

STING activation enhances immunotherapy of AML

Dieter Kabelitz, Guranda Chitadze

Blood (2025) 145 (19): 2106–2108.

https://doi.org/10.1182/blood.2025028653

Published: 2025

Journal Articles

GATA 2 much: stemness and resistance in AML chemotherapy

Thomas Mercher, Marie-Laure Arcangeli

Blood (2025) 145 (19): 2110–2112.

https://doi.org/10.1182/blood.2024028200

Published: 2025

Journal Articles

Epigenetics-based stratification in pediatric T-ALL

Mathieu Simonin, Aurore Touzart

Blood (2025) 145 (19): 2108–2110.

https://doi.org/10.1182/blood.2024028016

Published: 2025

Journal Articles

Myelodysplastic neoplasm with biallelic TP53 inactivation in a patient with plasma cell myeloma after cytotoxic therapy

Rong He, Dong Chen

Blood (2025) 145 (19): 2230.

https://doi.org/10.1182/blood.2024028288

Published: 2025

Journal Articles

Luskin MR, Murakami MA, Keating J, et al. Asciminib plus dasatinib and prednisone for Philadelphia chromosome–positive acute leukemia. Blood. 2025;145(6):577-589.

Blood (2025) 145 (19): 2231.

https://doi.org/10.1182/blood.2025029277

Published: 2025

Journal Articles

Babesia not only is invasive but creates RBC inflexibility

Ryan P. Jajosky, Sean R. Stowell

Blood (2025) 145 (19): 2114–2115.

https://doi.org/10.1182/blood.2025028446

Published: 2025

Journal Articles

Seeking an escape door from the maze of cGVHD

Yoshinobu Maeda

Blood (2025) 145 (19): 2115–2116.

https://doi.org/10.1182/blood.2025028581

Published: 2025

Journal Articles

Clonal γδ T-cell proliferation associated with Babesia infection: a rare and challenging diagnostic pitfall

Habibe Kurt, Sam Sadigh

Blood (2025) 145 (19): 2229.

https://doi.org/10.1182/blood.2025028400

Published: 2025

Journal Articles

NETs persisting in vasculature undergo self-renewal with consequences for subsequent infection: a mouse model study

Michal Santocki, Anna Such, Dominika Drab, Gabriela Burczyk, Elzbieta Kolaczkowska

Blood (2025) 145 (18): 2070–2085.

https://doi.org/10.1182/blood.2024026643

Published: 2025

Includes: Multimedia, Supplemental data

Journal Articles

Clinical-genomic profiling of MDS to inform allo-HCT: recommendations from an international panel on behalf of the EBMT

Blood (2025) 145 (18): 1987–2001.

https://doi.org/10.1182/blood.2024025131

Published: 2025

Includes: Supplemental data

Journal Articles

Class struggle in DLBCL

Joanna A. Krupka, Daniel J. Hodson

Blood (2025) 145 (18): 1967–1969.

https://doi.org/10.1182/blood.2024027995

Published: 2025

Journal Articles

When lymphoma mimics adenocarcinoma: signet ring morphology in follicular lymphoma

Xenia Parisi, L. Jeffrey Medeiros

Blood (2025) 145 (18): 2104.

https://doi.org/10.1182/blood.2025028395

Published: 2025

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Measurable residual disease and posttransplantation gilteritinib maintenance for patients with FLT3-ITD –mutated AML

CpG island methylator phenotype classification improves risk assessment in pediatric T-cell acute lymphoblastic leukemia

The JAK2 46/1 haplotype influences PD-L1 expression

STING activation improves T-cell-engaging immunotherapy for acute myeloid leukemia

Hu L, Shi Y, Hsu J, Gera J, Van Ness B, Lichtenstein A. Downstream effectors of oncogenic ras in multiple myeloma cells. Blood . 2003;101(8):3126-3135.

Lee HJ, Ramchandren R, Friedman J, et al. Brentuximab vedotin, nivolumab, doxorubicin, and dacarbazine for advanced-stage classical Hodgkin lymphoma. Blood. 2025;145(3):290-299.

3D insights: JAK2 46/1 haplotype shapes MPN development

From prognostication to precision in acute myeloid leukemia

STING activation enhances immunotherapy of AML

GATA 2 much: stemness and resistance in AML chemotherapy

Epigenetics-based stratification in pediatric T-ALL

Myelodysplastic neoplasm with biallelic TP53 inactivation in a patient with plasma cell myeloma after cytotoxic therapy

Luskin MR, Murakami MA, Keating J, et al. Asciminib plus dasatinib and prednisone for Philadelphia chromosome–positive acute leukemia. Blood. 2025;145(6):577-589.

Babesia not only is invasive but creates RBC inflexibility

Seeking an escape door from the maze of cGVHD

Clonal γδ T-cell proliferation associated with Babesia infection: a rare and challenging diagnostic pitfall

NETs persisting in vasculature undergo self-renewal with consequences for subsequent infection: a mouse model study

Clinical-genomic profiling of MDS to inform allo-HCT: recommendations from an international panel on behalf of the EBMT

Class struggle in DLBCL

When lymphoma mimics adenocarcinoma: signet ring morphology in follicular lymphoma

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only